deltatrials
Terminated EARLY_PHASE1 INTERVENTIONAL 2-arm NCT04630353

A Study HB-201 in Patients With Newly Diagnosed HPV16+ Oropharynx or Locally Advanced Cervical Cancer

A Phase 0 Trial of HB-201 for Subjects With Transoral Resectable Human Papillomavirus 16 Positive (HPV 16+) Oropharynx Cancer or With Locally Advanced Cervical Cancer Treated With Chemotherapy and Radiation

Sponsor: Hookipa Biotech GmbH

Conditions HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer
Interventions HB-201 IV
Updated 34 times since 2020 Last updated: Sep 8, 2025 Started: Jul 28, 2021 Primary completion: Nov 28, 2023 Completion: Nov 28, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Sponsor decision.

Other terminated trials from Hookipa Biotech GmbH

More terminations from Hookipa Biotech GmbH

This EARLY_PHASE1 trial investigates HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer and is currently terminated or withdrawn. Hookipa Biotech GmbH leads this study, which shows 34 recorded versions since 2021 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Sep 2021 · 6 months · monthly snapshot~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Nov 2021 · 31 days · monthly snapshot~Nov 2021 – ~Dec 2021 · 30 days · monthly snapshot~Dec 2021 – ~Jan 2022 · 31 days · monthly snapshot~Jan 2022 – ~Feb 2022 · 31 days · monthly snapshot~Feb 2022 – ~Mar 2022 · 28 days · monthly snapshot~Mar 2022 – ~Apr 2022 · 31 days · monthly snapshot~Apr 2022 – ~May 2022 · 30 days · monthly snapshot~May 2022 – ~Jun 2022 · 31 days · monthly snapshot~Jun 2022 – ~Jul 2022 · 30 days · monthly snapshot~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshot~Sep 2022 – ~Nov 2022 · 2 months · monthly snapshot~Nov 2022 – ~Dec 2022 · 30 days · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Feb 2023 · 31 days · monthly snapshot~Feb 2023 – ~Mar 2023 · 28 days · monthly snapshot~Mar 2023 – ~Apr 2023 · 31 days · monthly snapshot~Apr 2023 – ~May 2023 · 30 days · monthly snapshot~May 2023 – ~Jun 2023 · 31 days · monthly snapshot~Jun 2023 – ~Aug 2023 · 2 months · monthly snapshot~Aug 2023 – ~Sep 2023 · 31 days · monthly snapshot~Sep 2023 – ~Oct 2023 · 30 days · monthly snapshot~Oct 2023 – ~Nov 2023 · 31 days · monthly snapshot~Nov 2023 – ~Dec 2023 · 30 days · monthly snapshot~Dec 2023 – ~Jan 2024 · 31 days · monthly snapshot~Jan 2024 – ~Mar 2024 · 2 months · monthly snapshot~Mar 2024 – ~Apr 2024 · 31 days · monthly snapshot~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Oct 2025 · 13 months · monthly snapshot~Oct 2025 – present · 11 months · monthly snapshot

Change History

34 versions recorded

  1. Oct 2025 — Present [monthly]

    Terminated EARLY_PHASE1

  2. Sep 2024 — Oct 2025 [monthly]

    Terminated EARLY_PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated EARLY_PHASE1

  4. Apr 2024 — Jul 2024 [monthly]

    Terminated EARLY_PHASE1

  5. Mar 2024 — Apr 2024 [monthly]

    Terminated EARLY_PHASE1

▶ Show 29 earlier versions

  1. Jan 2024 — Mar 2024 [monthly]

    Terminated EARLY_PHASE1

    Status: Recruiting → Terminated

  2. Dec 2023 — Jan 2024 [monthly]

    Recruiting EARLY_PHASE1

  3. Nov 2023 — Dec 2023 [monthly]

    Recruiting EARLY_PHASE1

  4. Oct 2023 — Nov 2023 [monthly]

    Recruiting EARLY_PHASE1

  5. Sep 2023 — Oct 2023 [monthly]

    Recruiting EARLY_PHASE1

  6. Aug 2023 — Sep 2023 [monthly]

    Recruiting EARLY_PHASE1

  7. Jun 2023 — Aug 2023 [monthly]

    Recruiting EARLY_PHASE1

  8. May 2023 — Jun 2023 [monthly]

    Recruiting EARLY_PHASE1

  9. Apr 2023 — May 2023 [monthly]

    Recruiting EARLY_PHASE1

  10. Mar 2023 — Apr 2023 [monthly]

    Recruiting EARLY_PHASE1

  11. Feb 2023 — Mar 2023 [monthly]

    Recruiting EARLY_PHASE1

  12. Jan 2023 — Feb 2023 [monthly]

    Recruiting EARLY_PHASE1

  13. Dec 2022 — Jan 2023 [monthly]

    Recruiting EARLY_PHASE1

  14. Nov 2022 — Dec 2022 [monthly]

    Recruiting EARLY_PHASE1

  15. Sep 2022 — Nov 2022 [monthly]

    Recruiting EARLY_PHASE1

  16. Jul 2022 — Sep 2022 [monthly]

    Recruiting EARLY_PHASE1

  17. Jun 2022 — Jul 2022 [monthly]

    Recruiting EARLY_PHASE1

  18. May 2022 — Jun 2022 [monthly]

    Recruiting EARLY_PHASE1

  19. Apr 2022 — May 2022 [monthly]

    Recruiting EARLY_PHASE1

  20. Mar 2022 — Apr 2022 [monthly]

    Recruiting EARLY_PHASE1

  21. Feb 2022 — Mar 2022 [monthly]

    Recruiting EARLY_PHASE1

  22. Jan 2022 — Feb 2022 [monthly]

    Recruiting EARLY_PHASE1

  23. Dec 2021 — Jan 2022 [monthly]

    Recruiting EARLY_PHASE1

  24. Nov 2021 — Dec 2021 [monthly]

    Recruiting EARLY_PHASE1

  25. Oct 2021 — Nov 2021 [monthly]

    Recruiting EARLY_PHASE1

  26. Sep 2021 — Oct 2021 [monthly]

    Recruiting EARLY_PHASE1

  27. Mar 2021 — Sep 2021 [monthly]

    Recruiting EARLY_PHASE1

    Status: Not Yet Recruiting → Recruiting

  28. Jan 2021 — Mar 2021 [monthly]

    Not Yet Recruiting EARLY_PHASE1

  29. Dec 2020 — Jan 2021 [monthly]

    Not Yet Recruiting EARLY_PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hookipa Biotech GmbH
Data source: Hookipa Biotech GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations